On July 16, the 10th and final participant completed their 12-month follow-up interview in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study has treated 10 subjects with chronic, treatment-resistant PTSD from any cause. All treatment sessions and long-term follow-up interviews for this study have now been completed. Data from this study will be included in an international meta-analysis of the safety and efficacy of MDMA-assisted psychotherapy for the treatment of PTSD. Learn more…
